| Lisa S Rosen, MD | |
|
250 King Of Prussia Rd, Radnor, PA 19087 | |
| (610) 902-2000 | |
| Not Available |
| Full Name | Lisa S Rosen |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 250 King Of Prussia Rd, Radnor, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053351395 | NPI | - | NPPES |
| 0011354810001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD035433E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lisa S Rosen, MD 250 King Of Prussia Rd, Radnor, PA 19087 Ph: () - | Lisa S Rosen, MD 250 King Of Prussia Rd, Radnor, PA 19087 Ph: (610) 902-2000 |
News Archive
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced dosing of the first patients enrolled in the Company's Phase 2b study of PG324, a novel, fixed-combination of Aerie's AR-13324 and latanoprost, a prostaglandin analogue that is the most widely prescribed glaucoma drug.
A team of researchers led by Osaka University examined the dissemination of colistin-resistant bacteria among residents of rural communities in Vietnam to find that the prevalence of colistin-resistant Escherichia coli in the intestines was extremely high, at about 70 percent.
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a focus primarily in oncology, today announced that it has received $50 million from existing institutional investors in a previously announced registered direct offering.
Failing an exam at school, getting rejected for a job or being screamed at by your teacher or superior are only a few examples of situations that may cause despair, disappointment or a sense of failure.
Bionik Laboratories Corp., a pioneering medical device and robotics company with a focus in developing transformational technologies and solutions for individuals with neurological disorders, announced that shares of the Company's common stock will begin trading today on the OTCQX® Best Market under its existing ticker symbol "BNKL."
› Verified 3 days ago
Michelle D Vichnin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 250 King Of Prussia Road, Radnor, PA 19087 Phone: 610-902-2000 Fax: 610-902-5704 | |
Ryan Elizabeth Offer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 250 King Of Prussia Rd, Radnor, PA 19087 Phone: 610-902-2500 Fax: 610-902-2531 | |
Ann L Honebrink, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 250 King Of Prussia Rd, Penn Med At Radnor, Radnor, PA 19087 Phone: 610-902-2525 Fax: 610-902-2504 | |
Dr. Frank Norman Berry, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 702 Weadley Rd, Radnor, PA 19087 Phone: 301-814-4477 | |
Dr. Emelia Argyropoulos Bachman, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 250 King Of Prussia Rd, Radnor, PA 19087 Phone: 610-902-2500 Fax: 610-902-2531 | |
Ann L Steiner, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 250 King Of Prussia Rd, Radnor, PA 19087 Phone: 610-902-2500 Fax: 610-902-1845 |